Clicky

Health

Celebrate the Holidays with Festive Mexican Favorites

2560 1707 Tori

As you gather with loved ones for the holidays, you can enhance the magic of the season by adding Chispa – a special spark – to your dinner table. It’s as easy as adding classic…

Put a Plant-Based Twist on Holiday Baking

2253 1500 Jane

Flavorful desserts are a staple of the holidays and the exciting, appetizing allure of new recipes can help elevate seasonal gatherings and create sweet memories. With near-endless options for celebrating the season, putting a plant-based…

The Critical Role of TCS Tech in Building Capacity for International Medical Corps

2560 1707 Todd

At TCS, we are building on the belief that business can be a catalyst for change. Our purpose is to connect people to opportunities in the digital economy and that mission is central to the…

Health Canada Authorizes Moderna’s Omicron-Targeting Bivalent COVID-19 Booster Vaccine

1200 277 Robert

Study results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and BA.4/5 subvariants when compared with mRNA-1273 Approval follows agreement with the Government of Canada to supply 12 million doses of Omicron-targeting…

Therapeutic Goods Administration Provisionally Approves Moderna’s Omicron-Containing Bivalent Booster Candidate, MRNA-1273.214, For Australia

1200 277 Tori

Australia becomes among the first countries in the world to approve the use of a next-generation bivalent COVID-19 vaccine mRNA-1273.214, an Omicron-containing bivalent vaccine, has demonstrated significantly higher antibody titers against all tested variants, including…

Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years

1200 277 Robert

CAMBRIDGE, MA / ACCESSWIRE / July 18, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration…

Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement

1200 277 admin

CAMBRIDGE, MA / ACCESSWIRE / June 2, 2022 / Moderna, Inc.(NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement with the European Commission (EC) to amend their originally agreed contractual…

Empower Clinics Granted Accreditation For Mobile Covid-19 Testing Solutions Throughout British Columbia

270 50 Robert

VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms, a medical device company, and a high…

IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program

1200 277 Merci

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY and CAMBRIDGE, MA / ACCESSWIRE / May 18,…

Moderna to Host Annual Science and Technology Day on May 17, 2022

1200 277 Merci

CAMBRIDGE, MA / ACCESSWIRE / May 9, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that that it will host its in-person Science and Technology Day for…